AMBBY
Price
$12.96
Change
+$0.40 (+3.18%)
Updated
Nov 11 closing price
Capitalization
3.49B
Intraday BUY SELL Signals
ANSLF
Price
$23.80
Change
+$0.06 (+0.25%)
Updated
Nov 11 closing price
Capitalization
3.46B
Intraday BUY SELL Signals
Interact to see
Advertisement

AMBBY vs ANSLF

Header iconAMBBY vs ANSLF Comparison
Open Charts AMBBY vs ANSLFBanner chart's image
Ambu A/S
Price$12.96
Change+$0.40 (+3.18%)
Volume$700
Capitalization3.49B
Ansell
Price$23.80
Change+$0.06 (+0.25%)
Volume$968
Capitalization3.46B
AMBBY vs ANSLF Comparison Chart in %
AMBBY
Daily Signal:
Gain/Loss:
ANSLF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMBBY vs. ANSLF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBBY is a Hold and ANSLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AMBBY: $12.96 vs. ANSLF: $23.81)
Brand notoriety: AMBBY and ANSLF are both not notable
AMBBY represents the Medical/Nursing Services, while ANSLF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMBBY: 42% vs. ANSLF: 141%
Market capitalization -- AMBBY: $3.49B vs. ANSLF: $3.46B
AMBBY [@Medical/Nursing Services] is valued at $3.49B. ANSLF’s [@Pharmaceuticals: Other] market capitalization is $3.46B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $224B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $202.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMBBY’s FA Score shows that 0 FA rating(s) are green whileANSLF’s FA Score has 1 green FA rating(s).

  • AMBBY’s FA Score: 0 green, 5 red.
  • ANSLF’s FA Score: 1 green, 4 red.
According to our system of comparison, ANSLF is a better buy in the long-term than AMBBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMBBY’s TA Score shows that 3 TA indicator(s) are bullish while ANSLF’s TA Score has 2 bullish TA indicator(s).

  • AMBBY’s TA Score: 3 bullish, 6 bearish.
  • ANSLF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ANSLF is a better buy in the short-term than AMBBY.

Price Growth

AMBBY (@Medical/Nursing Services) experienced а +3.18% price change this week, while ANSLF (@Pharmaceuticals: Other) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was +6.19%.

Industries' Descriptions

@Medical/Nursing Services (+0.41% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.62% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMBBY($3.49B) and ANSLF($3.46B) have the same market capitalization . AMBBY has higher P/E ratio than ANSLF: AMBBY (36.64) vs ANSLF (34.25). ANSLF YTD gains are higher at: 1.644 vs. AMBBY (-0.461). AMBBY has higher annual earnings (EBITDA): 830M vs. ANSLF (260M). AMBBY has more cash in the bank: 751M vs. ANSLF (238M). AMBBY has less debt than ANSLF: AMBBY (534M) vs ANSLF (806M). AMBBY has higher revenues than ANSLF: AMBBY (5.96B) vs ANSLF (2B).
AMBBYANSLFAMBBY / ANSLF
Capitalization3.49B3.46B101%
EBITDA830M260M319%
Gain YTD-0.4611.644-28%
P/E Ratio36.6434.25107%
Revenue5.96B2B297%
Total Cash751M238M316%
Total Debt534M806M66%
FUNDAMENTALS RATINGS
AMBBY vs ANSLF: Fundamental Ratings
AMBBY
ANSLF
OUTLOOK RATING
1..100
8248
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8190
PRICE GROWTH RATING
1..100
8446
P/E GROWTH RATING
1..100
9847
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANSLF's Valuation (19) in the null industry is significantly better than the same rating for AMBBY (97). This means that ANSLF’s stock grew significantly faster than AMBBY’s over the last 12 months.

ANSLF's Profit vs Risk Rating (100) in the null industry is in the same range as AMBBY (100). This means that ANSLF’s stock grew similarly to AMBBY’s over the last 12 months.

AMBBY's SMR Rating (81) in the null industry is in the same range as ANSLF (90). This means that AMBBY’s stock grew similarly to ANSLF’s over the last 12 months.

ANSLF's Price Growth Rating (46) in the null industry is somewhat better than the same rating for AMBBY (84). This means that ANSLF’s stock grew somewhat faster than AMBBY’s over the last 12 months.

ANSLF's P/E Growth Rating (47) in the null industry is somewhat better than the same rating for AMBBY (98). This means that ANSLF’s stock grew somewhat faster than AMBBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMBBYANSLF
RSI
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
45%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
32%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
21%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
15%
View a ticker or compare two or three
Interact to see
Advertisement
AMBBY
Daily Signal:
Gain/Loss:
ANSLF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAMVX29.260.14
+0.48%
Harbor Mid Cap Value Instl
NBIIX15.040.07
+0.47%
Neuberger Berman International Eq I
DIEAX46.190.19
+0.41%
BNY Mellon International Core Equity A
FNEEX79.140.21
+0.27%
American Funds New Economy 529-F-2
FGDCX46.56N/A
N/A
Fidelity Advisor Gold C

AMBBY and

Correlation & Price change

A.I.dvisor tells us that AMBBY and AZTA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMBBY and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMBBY
1D Price
Change %
AMBBY100%
N/A
AZTA - AMBBY
24%
Poorly correlated
+0.36%
CLPBY - AMBBY
23%
Poorly correlated
+0.64%
GNNDY - AMBBY
23%
Poorly correlated
+6.04%
ALGN - AMBBY
23%
Poorly correlated
-1.94%
VTAK - AMBBY
21%
Poorly correlated
-0.43%
More

ANSLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANSLF has been loosely correlated with PXMBF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLF jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANSLF
1D Price
Change %
ANSLF100%
N/A
PXMBF - ANSLF
37%
Loosely correlated
N/A
MASI - ANSLF
22%
Poorly correlated
+2.12%
CNTGF - ANSLF
21%
Poorly correlated
N/A
AMBBY - ANSLF
11%
Poorly correlated
N/A
BBLG - ANSLF
3%
Poorly correlated
+2.31%
More